Craft

SeQuent Scientific

Stock Price

₹173.4

2024-10-29

Market Capitalization

₹45.4 B

2024-10-29

Revenue

₹15.5 B

FY, 2025

SeQuent Scientific Summary

Company Summary

Overview
SeQuent Scientific (formerly PI Drugs and Pharmaceuticals) is a pharmaceutical company active in the animal health sector and contract research focusing on analytical and bioanalytical services. It produces animal health active pharmaceutical ingredients (APIs), human APIs, and finished dosage formulations in the areas of feed supplements, antibiotics, antibacterial, anthelmintics, antiprotozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs, and dermatology. Its analytical solutions include method validation, stability, and microbiology for APIs and finished products.
Type
Public
Status
Active
Founded
2002
HQ
Thane, IN | view all locations
Website
http://sequent.in
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

3 locations detected

  • Thane, MH HQ

    India

    Unit No G1, Dosti Pinnacle, Plot No E7, Rd Number 22, Wagle Industrial Estate, Thane West

  • Jigani, KA

    India

  • Mangalore, KA

    India

    Industrial Area Rd, New Mangalore, Industrial Area, Baikampady

SeQuent Scientific Financials

Summary Financials

Revenue (Q3, 2026)
₹8.6B
Gross profit (Q3, 2026)
₹4.8B
Net income (Q3, 2026)
₹485.2M
Cash (Q2, 2026)
₹708.3M
EBIT (Q3, 2026)
₹898.2M
Enterprise value
$49.6B

Footer menu